id	sid	tid	token	lemma	pos
cord-329200-o5hxpl8f	1	1	key	key	JJ
cord-329200-o5hxpl8f	2	1	:	:	:
cord-329200-o5hxpl8f	2	2	cord-329200-o5hxpl8f	cord-329200-o5hxpl8f	NNP
cord-329200-o5hxpl8f	2	3	authors	author	NNS
cord-329200-o5hxpl8f	2	4	:	:	:
cord-329200-o5hxpl8f	2	5	Houlihan	Houlihan	NNP
cord-329200-o5hxpl8f	2	6	,	,	,
cord-329200-o5hxpl8f	2	7	Catherine	Catherine	NNP
cord-329200-o5hxpl8f	2	8	F	F	NNP
cord-329200-o5hxpl8f	2	9	;	;	:
cord-329200-o5hxpl8f	2	10	Beale	Beale	NNP
cord-329200-o5hxpl8f	2	11	,	,	,
cord-329200-o5hxpl8f	2	12	Rupert	Rupert	NNP
cord-329200-o5hxpl8f	3	1	title	title	NN
cord-329200-o5hxpl8f	3	2	:	:	:
cord-329200-o5hxpl8f	4	1	The	the	DT
cord-329200-o5hxpl8f	4	2	complexities	complexity	NNS
cord-329200-o5hxpl8f	4	3	of	of	IN
cord-329200-o5hxpl8f	4	4	SARS	SARS	NNP
cord-329200-o5hxpl8f	4	5	-	-	HYPH
cord-329200-o5hxpl8f	4	6	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	4	7	serology	serology	NN
cord-329200-o5hxpl8f	4	8	date	date	NN
cord-329200-o5hxpl8f	4	9	:	:	:
cord-329200-o5hxpl8f	4	10	2020	2020	CD
cord-329200-o5hxpl8f	4	11	-	-	HYPH
cord-329200-o5hxpl8f	4	12	09	09	CD
cord-329200-o5hxpl8f	4	13	-	-	SYM
cord-329200-o5hxpl8f	4	14	23	23	CD
cord-329200-o5hxpl8f	4	15	journal	journal	NN
cord-329200-o5hxpl8f	4	16	:	:	:
cord-329200-o5hxpl8f	5	1	Lancet	Lancet	NNP
cord-329200-o5hxpl8f	5	2	Infect	infect	VB
cord-329200-o5hxpl8f	5	3	Dis	dis	NN
cord-329200-o5hxpl8f	5	4	DOI	doi	NN
cord-329200-o5hxpl8f	6	1	:	:	:
cord-329200-o5hxpl8f	6	2	10.1016	10.1016	CD
cord-329200-o5hxpl8f	6	3	/	/	SYM
cord-329200-o5hxpl8f	6	4	s1473	s1473	NN
cord-329200-o5hxpl8f	6	5	-	-	NN
cord-329200-o5hxpl8f	6	6	3099(20)30699-x	3099(20)30699-x	CD
cord-329200-o5hxpl8f	7	1	sha	sha	NNP
cord-329200-o5hxpl8f	7	2	:	:	:
cord-329200-o5hxpl8f	8	1	657ec714cc9cf2cc40639081c0b342b7cee54126	657ec714cc9cf2cc40639081c0b342b7cee54126	CD
cord-329200-o5hxpl8f	9	1	doc_id	doc_id	CD
cord-329200-o5hxpl8f	9	2	:	:	:
cord-329200-o5hxpl8f	9	3	329200	329200	CD
cord-329200-o5hxpl8f	9	4	cord_uid	cord_uid	NNS
cord-329200-o5hxpl8f	9	5	:	:	:
cord-329200-o5hxpl8f	10	1	o5hxpl8f	o5hxpl8f	NNP
cord-329200-o5hxpl8f	10	2	nan	nan	NNP
cord-329200-o5hxpl8f	10	3	Diagnosing	diagnose	VBG
cord-329200-o5hxpl8f	10	4	previous	previous	JJ
cord-329200-o5hxpl8f	10	5	infection	infection	NN
cord-329200-o5hxpl8f	10	6	with	with	IN
cord-329200-o5hxpl8f	10	7	respiratory	respiratory	JJ
cord-329200-o5hxpl8f	10	8	viruses	virus	NNS
cord-329200-o5hxpl8f	10	9	is	be	VBZ
cord-329200-o5hxpl8f	10	10	challenging	challenging	JJ
cord-329200-o5hxpl8f	10	11	.	.	.
cord-329200-o5hxpl8f	11	1	Our	-PRON-	PRP$
cord-329200-o5hxpl8f	11	2	understanding	understanding	NN
cord-329200-o5hxpl8f	11	3	of	of	IN
cord-329200-o5hxpl8f	11	4	individual	individual	NN
cord-329200-o5hxpl8f	11	5	and	and	CC
cord-329200-o5hxpl8f	11	6	population	population	NN
cord-329200-o5hxpl8f	11	7	-	-	HYPH
cord-329200-o5hxpl8f	11	8	level	level	NN
cord-329200-o5hxpl8f	11	9	immunity	immunity	NN
cord-329200-o5hxpl8f	11	10	to	to	IN
cord-329200-o5hxpl8f	11	11	severe	severe	JJ
cord-329200-o5hxpl8f	11	12	acute	acute	JJ
cord-329200-o5hxpl8f	11	13	respiratory	respiratory	JJ
cord-329200-o5hxpl8f	11	14	syndrome	syndrome	NN
cord-329200-o5hxpl8f	11	15	coronavirus	coronavirus	NN
cord-329200-o5hxpl8f	11	16	2	2	CD
cord-329200-o5hxpl8f	11	17	(	(	-LRB-
cord-329200-o5hxpl8f	11	18	SARS	SARS	NNP
cord-329200-o5hxpl8f	11	19	-	-	HYPH
cord-329200-o5hxpl8f	11	20	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	11	21	)	)	-RRB-
cord-329200-o5hxpl8f	11	22	remains	remain	VBZ
cord-329200-o5hxpl8f	11	23	incomplete	incomplete	JJ
cord-329200-o5hxpl8f	11	24	and	and	CC
cord-329200-o5hxpl8f	11	25	developing	develop	VBG
cord-329200-o5hxpl8f	11	26	reliable	reliable	JJ
cord-329200-o5hxpl8f	11	27	serological	serological	JJ
cord-329200-o5hxpl8f	11	28	assays	assay	NNS
cord-329200-o5hxpl8f	11	29	to	to	TO
cord-329200-o5hxpl8f	11	30	detect	detect	VB
cord-329200-o5hxpl8f	11	31	previous	previous	JJ
cord-329200-o5hxpl8f	11	32	infection	infection	NN
cord-329200-o5hxpl8f	11	33	has	have	VBZ
cord-329200-o5hxpl8f	11	34	been	be	VBN
cord-329200-o5hxpl8f	11	35	an	an	DT
cord-329200-o5hxpl8f	11	36	intense	intense	JJ
cord-329200-o5hxpl8f	11	37	focus	focus	NN
cord-329200-o5hxpl8f	11	38	of	of	IN
cord-329200-o5hxpl8f	11	39	the	the	DT
cord-329200-o5hxpl8f	11	40	global	global	JJ
cord-329200-o5hxpl8f	11	41	scientific	scientific	JJ
cord-329200-o5hxpl8f	11	42	effort	effort	NN
cord-329200-o5hxpl8f	11	43	.	.	.
cord-329200-o5hxpl8f	12	1	For	for	IN
cord-329200-o5hxpl8f	12	2	public	public	JJ
cord-329200-o5hxpl8f	12	3	health	health	NN
cord-329200-o5hxpl8f	12	4	planning	planning	NN
cord-329200-o5hxpl8f	12	5	we	-PRON-	PRP
cord-329200-o5hxpl8f	12	6	need	need	VBP
cord-329200-o5hxpl8f	12	7	scalable	scalable	JJ
cord-329200-o5hxpl8f	12	8	assays	assay	NNS
cord-329200-o5hxpl8f	12	9	validated	validate	VBN
cord-329200-o5hxpl8f	12	10	against	against	IN
cord-329200-o5hxpl8f	12	11	large	large	JJ
cord-329200-o5hxpl8f	12	12	banks	bank	NNS
cord-329200-o5hxpl8f	12	13	of	of	IN
cord-329200-o5hxpl8f	12	14	samples	sample	NNS
cord-329200-o5hxpl8f	12	15	from	from	IN
cord-329200-o5hxpl8f	12	16	individuals	individual	NNS
cord-329200-o5hxpl8f	12	17	who	who	WP
cord-329200-o5hxpl8f	12	18	had	have	VBD
cord-329200-o5hxpl8f	12	19	proven	prove	VBN
cord-329200-o5hxpl8f	12	20	seasonal	seasonal	JJ
cord-329200-o5hxpl8f	12	21	(	(	-LRB-
cord-329200-o5hxpl8f	12	22	non	non	JJ
cord-329200-o5hxpl8f	12	23	-	-	JJ
cord-329200-o5hxpl8f	12	24	severe	severe	JJ
cord-329200-o5hxpl8f	12	25	acute	acute	JJ
cord-329200-o5hxpl8f	12	26	respiratory	respiratory	JJ
cord-329200-o5hxpl8f	12	27	syndrome	syndrome	NN
cord-329200-o5hxpl8f	12	28	)	)	-RRB-
cord-329200-o5hxpl8f	12	29	coronaviruses	coronaviruse	NNS
cord-329200-o5hxpl8f	12	30	and	and	CC
cord-329200-o5hxpl8f	12	31	those	those	DT
cord-329200-o5hxpl8f	12	32	who	who	WP
cord-329200-o5hxpl8f	12	33	had	have	VBD
cord-329200-o5hxpl8f	12	34	well	well	RB
cord-329200-o5hxpl8f	12	35	characterised	characterise	VBN
cord-329200-o5hxpl8f	12	36	symptomatic	symptomatic	JJ
cord-329200-o5hxpl8f	12	37	and	and	CC
cord-329200-o5hxpl8f	12	38	asymptomatic	asymptomatic	JJ
cord-329200-o5hxpl8f	12	39	confirmed	confirm	VBN
cord-329200-o5hxpl8f	12	40	SARS	SARS	NNP
cord-329200-o5hxpl8f	12	41	-	-	HYPH
cord-329200-o5hxpl8f	12	42	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	12	43	infection	infection	NN
cord-329200-o5hxpl8f	12	44	.	.	.
cord-329200-o5hxpl8f	13	1	False	false	JJ
cord-329200-o5hxpl8f	13	2	-	-	HYPH
cord-329200-o5hxpl8f	13	3	positive	positive	JJ
cord-329200-o5hxpl8f	13	4	results	result	NNS
cord-329200-o5hxpl8f	13	5	,	,	,
cord-329200-o5hxpl8f	13	6	due	due	IN
cord-329200-o5hxpl8f	13	7	to	to	IN
cord-329200-o5hxpl8f	13	8	crossreactivity	crossreactivity	NN
cord-329200-o5hxpl8f	13	9	with	with	IN
cord-329200-o5hxpl8f	13	10	seasonal	seasonal	JJ
cord-329200-o5hxpl8f	13	11	coronaviruses	coronaviruse	NNS
cord-329200-o5hxpl8f	13	12	,	,	,
cord-329200-o5hxpl8f	13	13	are	be	VBP
cord-329200-o5hxpl8f	13	14	important	important	JJ
cord-329200-o5hxpl8f	13	15	to	to	TO
cord-329200-o5hxpl8f	13	16	avoid	avoid	VB
cord-329200-o5hxpl8f	13	17	,	,	,
cord-329200-o5hxpl8f	13	18	particularly	particularly	RB
cord-329200-o5hxpl8f	13	19	if	if	IN
cord-329200-o5hxpl8f	13	20	seropositive	seropositive	NNS
cord-329200-o5hxpl8f	13	21	-	-	HYPH
cord-329200-o5hxpl8f	13	22	individuals	individual	NNS
cord-329200-o5hxpl8f	13	23	consider	consider	VBP
cord-329200-o5hxpl8f	13	24	themselves	-PRON-	PRP
cord-329200-o5hxpl8f	13	25	immune	immune	JJ
cord-329200-o5hxpl8f	13	26	.	.	.
cord-329200-o5hxpl8f	14	1	In	in	IN
cord-329200-o5hxpl8f	14	2	The	the	DT
cord-329200-o5hxpl8f	14	3	Lancet	Lancet	NNP
cord-329200-o5hxpl8f	14	4	Infectious	Infectious	NNP
cord-329200-o5hxpl8f	14	5	Diseases	Diseases	NNPS
cord-329200-o5hxpl8f	14	6	,	,	,
cord-329200-o5hxpl8f	14	7	the	the	DT
cord-329200-o5hxpl8f	14	8	National	National	NNP
cord-329200-o5hxpl8f	14	9	SARS	SARS	NNP
cord-329200-o5hxpl8f	14	10	-	-	HYPH
cord-329200-o5hxpl8f	14	11	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	14	12	Serology	Serology	NNP
cord-329200-o5hxpl8f	14	13	Assay	Assay	NNP
cord-329200-o5hxpl8f	14	14	Evaluation	Evaluation	NNP
cord-329200-o5hxpl8f	14	15	Group	Group	NNP
cord-329200-o5hxpl8f	14	16	1	1	CD
cord-329200-o5hxpl8f	14	17	provide	provide	VBP
cord-329200-o5hxpl8f	14	18	the	the	DT
cord-329200-o5hxpl8f	14	19	first	first	JJ
cord-329200-o5hxpl8f	14	20	large	large	JJ
cord-329200-o5hxpl8f	14	21	comparative	comparative	JJ
cord-329200-o5hxpl8f	14	22	investigation	investigation	NN
cord-329200-o5hxpl8f	14	23	of	of	IN
cord-329200-o5hxpl8f	14	24	the	the	DT
cord-329200-o5hxpl8f	14	25	performance	performance	NN
cord-329200-o5hxpl8f	14	26	of	of	IN
cord-329200-o5hxpl8f	14	27	four	four	CD
cord-329200-o5hxpl8f	14	28	widely	widely	RB
cord-329200-o5hxpl8f	14	29	available	available	JJ
cord-329200-o5hxpl8f	14	30	commercial	commercial	JJ
cord-329200-o5hxpl8f	14	31	assays	assay	NNS
cord-329200-o5hxpl8f	14	32	and	and	CC
cord-329200-o5hxpl8f	14	33	a	a	DT
cord-329200-o5hxpl8f	14	34	single	single	JJ
cord-329200-o5hxpl8f	14	35	in	in	IN
cord-329200-o5hxpl8f	14	36	-	-	HYPH
cord-329200-o5hxpl8f	14	37	house	house	NN
cord-329200-o5hxpl8f	14	38	assay	assay	NN
cord-329200-o5hxpl8f	14	39	.	.	.
cord-329200-o5hxpl8f	15	1	Antibody	antibody	NN
cord-329200-o5hxpl8f	15	2	responses	response	NNS
cord-329200-o5hxpl8f	15	3	to	to	IN
cord-329200-o5hxpl8f	15	4	SARS	SARS	NNP
cord-329200-o5hxpl8f	15	5	-	-	HYPH
cord-329200-o5hxpl8f	15	6	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	15	7	are	be	VBP
cord-329200-o5hxpl8f	15	8	predominantly	predominantly	RB
cord-329200-o5hxpl8f	15	9	directed	direct	VBN
cord-329200-o5hxpl8f	15	10	at	at	IN
cord-329200-o5hxpl8f	15	11	the	the	DT
cord-329200-o5hxpl8f	15	12	spike	spike	NN
cord-329200-o5hxpl8f	15	13	glycoprotein	glycoprotein	NN
cord-329200-o5hxpl8f	15	14	,	,	,
cord-329200-o5hxpl8f	15	15	which	which	WDT
cord-329200-o5hxpl8f	15	16	the	the	DT
cord-329200-o5hxpl8f	15	17	virus	virus	NN
cord-329200-o5hxpl8f	15	18	requires	require	VBZ
cord-329200-o5hxpl8f	15	19	for	for	IN
cord-329200-o5hxpl8f	15	20	entry	entry	NN
cord-329200-o5hxpl8f	15	21	,	,	,
cord-329200-o5hxpl8f	15	22	and	and	CC
cord-329200-o5hxpl8f	15	23	the	the	DT
cord-329200-o5hxpl8f	15	24	nucleocapsid	nucleocapsid	NNP
cord-329200-o5hxpl8f	15	25	protein	protein	NN
cord-329200-o5hxpl8f	15	26	,	,	,
cord-329200-o5hxpl8f	15	27	which	which	WDT
cord-329200-o5hxpl8f	15	28	binds	bind	VBZ
cord-329200-o5hxpl8f	15	29	the	the	DT
cord-329200-o5hxpl8f	15	30	viral	viral	JJ
cord-329200-o5hxpl8f	15	31	RNA	RNA	NNP
cord-329200-o5hxpl8f	15	32	genome	genome	NN
cord-329200-o5hxpl8f	15	33	.	.	.
cord-329200-o5hxpl8f	16	1	The	the	DT
cord-329200-o5hxpl8f	16	2	SARS	SARS	NNP
cord-329200-o5hxpl8f	16	3	-	-	HYPH
cord-329200-o5hxpl8f	16	4	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	16	5	IgG	igg	NN
cord-329200-o5hxpl8f	16	6	assay	assay	NN
cord-329200-o5hxpl8f	16	7	(	(	-LRB-
cord-329200-o5hxpl8f	16	8	Abbott	Abbott	NNP
cord-329200-o5hxpl8f	16	9	,	,	,
cord-329200-o5hxpl8f	16	10	Chicago	Chicago	NNP
cord-329200-o5hxpl8f	16	11	,	,	,
cord-329200-o5hxpl8f	16	12	IL	IL	NNP
cord-329200-o5hxpl8f	16	13	,	,	,
cord-329200-o5hxpl8f	16	14	USA	USA	NNP
cord-329200-o5hxpl8f	16	15	)	)	-RRB-
cord-329200-o5hxpl8f	16	16	and	and	CC
cord-329200-o5hxpl8f	16	17	Elecsys	Elecsys	NNP
cord-329200-o5hxpl8f	16	18	Anti	Anti	NNP
cord-329200-o5hxpl8f	16	19	-	-	NNP
cord-329200-o5hxpl8f	16	20	SARS	SARS	NNP
cord-329200-o5hxpl8f	16	21	-	-	HYPH
cord-329200-o5hxpl8f	16	22	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	16	23	assay	assay	NN
cord-329200-o5hxpl8f	16	24	(	(	-LRB-
cord-329200-o5hxpl8f	16	25	Roche	Roche	NNP
cord-329200-o5hxpl8f	16	26	,	,	,
cord-329200-o5hxpl8f	16	27	Basel	Basel	NNP
cord-329200-o5hxpl8f	16	28	,	,	,
cord-329200-o5hxpl8f	16	29	Switzerland	Switzerland	NNP
cord-329200-o5hxpl8f	16	30	)	)	-RRB-
cord-329200-o5hxpl8f	16	31	assays	assay	NNS
cord-329200-o5hxpl8f	16	32	detect	detect	VBP
cord-329200-o5hxpl8f	16	33	antibody	antibody	NN
cord-329200-o5hxpl8f	16	34	to	to	IN
cord-329200-o5hxpl8f	16	35	the	the	DT
cord-329200-o5hxpl8f	16	36	nucleoprotein	nucleoprotein	NNP
cord-329200-o5hxpl8f	16	37	,	,	,
cord-329200-o5hxpl8f	16	38	whereas	whereas	IN
cord-329200-o5hxpl8f	16	39	the	the	DT
cord-329200-o5hxpl8f	16	40	LIAISON	LIAISON	NNP
cord-329200-o5hxpl8f	16	41	SARS	SARS	NNP
cord-329200-o5hxpl8f	16	42	-	-	HYPH
cord-329200-o5hxpl8f	16	43	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	16	44	S1	S1	NNP
cord-329200-o5hxpl8f	16	45	/	/	SYM
cord-329200-o5hxpl8f	16	46	S2	S2	NNP
cord-329200-o5hxpl8f	16	47	IgG	IgG	NNP
cord-329200-o5hxpl8f	16	48	assay	assay	NN
cord-329200-o5hxpl8f	16	49	(	(	-LRB-
cord-329200-o5hxpl8f	16	50	DiaSorin	DiaSorin	NNP
cord-329200-o5hxpl8f	16	51	,	,	,
cord-329200-o5hxpl8f	16	52	Saluggia	Saluggia	NNP
cord-329200-o5hxpl8f	16	53	,	,	,
cord-329200-o5hxpl8f	16	54	Italy	Italy	NNP
cord-329200-o5hxpl8f	16	55	)	)	-RRB-
cord-329200-o5hxpl8f	16	56	,	,	,
cord-329200-o5hxpl8f	16	57	and	and	CC
cord-329200-o5hxpl8f	16	58	SARS	SARS	NNP
cord-329200-o5hxpl8f	16	59	-	-	HYPH
cord-329200-o5hxpl8f	16	60	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	16	61	Total	total	JJ
cord-329200-o5hxpl8f	16	62	assay	assay	NN
cord-329200-o5hxpl8f	16	63	(	(	-LRB-
cord-329200-o5hxpl8f	16	64	Siemens	Siemens	NNP
cord-329200-o5hxpl8f	16	65	,	,	,
cord-329200-o5hxpl8f	16	66	Munich	Munich	NNP
cord-329200-o5hxpl8f	16	67	,	,	,
cord-329200-o5hxpl8f	16	68	Germany	Germany	NNP
cord-329200-o5hxpl8f	16	69	)	)	-RRB-
cord-329200-o5hxpl8f	16	70	detect	detect	VBP
cord-329200-o5hxpl8f	16	71	antibodies	antibody	NNS
cord-329200-o5hxpl8f	16	72	to	to	IN
cord-329200-o5hxpl8f	16	73	the	the	DT
cord-329200-o5hxpl8f	16	74	spike	spike	NN
cord-329200-o5hxpl8f	16	75	glycoprotein	glycoprotein	NN
cord-329200-o5hxpl8f	16	76	.	.	.
cord-329200-o5hxpl8f	17	1	The	the	DT
cord-329200-o5hxpl8f	17	2	Abbott	Abbott	NNP
cord-329200-o5hxpl8f	17	3	and	and	CC
cord-329200-o5hxpl8f	17	4	Diasorin	Diasorin	NNP
cord-329200-o5hxpl8f	17	5	assays	assay	NNS
cord-329200-o5hxpl8f	17	6	detect	detect	VBP
cord-329200-o5hxpl8f	17	7	IgG	igg	NN
cord-329200-o5hxpl8f	17	8	only	only	RB
cord-329200-o5hxpl8f	17	9	,	,	,
cord-329200-o5hxpl8f	17	10	whereas	whereas	IN
cord-329200-o5hxpl8f	17	11	Roche	Roche	NNP
cord-329200-o5hxpl8f	17	12	and	and	CC
cord-329200-o5hxpl8f	17	13	Siemens	Siemens	NNP
cord-329200-o5hxpl8f	17	14	detect	detect	VBP
cord-329200-o5hxpl8f	17	15	total	total	JJ
cord-329200-o5hxpl8f	17	16	antibody	antibody	NN
cord-329200-o5hxpl8f	17	17	.	.	.
cord-329200-o5hxpl8f	18	1	The	the	DT
cord-329200-o5hxpl8f	18	2	diverse	diverse	JJ
cord-329200-o5hxpl8f	18	3	approaches	approach	NNS
cord-329200-o5hxpl8f	18	4	taken	take	VBN
cord-329200-o5hxpl8f	18	5	by	by	IN
cord-329200-o5hxpl8f	18	6	the	the	DT
cord-329200-o5hxpl8f	18	7	four	four	CD
cord-329200-o5hxpl8f	18	8	commercial	commercial	JJ
cord-329200-o5hxpl8f	18	9	assays	assay	NNS
cord-329200-o5hxpl8f	18	10	highlight	highlight	VBP
cord-329200-o5hxpl8f	18	11	the	the	DT
cord-329200-o5hxpl8f	18	12	challenge	challenge	NN
cord-329200-o5hxpl8f	18	13	of	of	IN
cord-329200-o5hxpl8f	18	14	choice	choice	NN
cord-329200-o5hxpl8f	18	15	posed	pose	VBN
cord-329200-o5hxpl8f	18	16	to	to	IN
cord-329200-o5hxpl8f	18	17	laboratories	laboratory	NNS
cord-329200-o5hxpl8f	18	18	:	:	:
cord-329200-o5hxpl8f	18	19	all	all	DT
cord-329200-o5hxpl8f	18	20	manufacturers	manufacturer	NNS
cord-329200-o5hxpl8f	18	21	report	report	VBP
cord-329200-o5hxpl8f	18	22	similarly	similarly	RB
cord-329200-o5hxpl8f	18	23	high	high	JJ
cord-329200-o5hxpl8f	18	24	sensitivity	sensitivity	NN
cord-329200-o5hxpl8f	18	25	and	and	CC
cord-329200-o5hxpl8f	18	26	specificity	specificity	NN
cord-329200-o5hxpl8f	18	27	.	.	.
cord-329200-o5hxpl8f	19	1	The	the	DT
cord-329200-o5hxpl8f	19	2	authors	author	NNS
cord-329200-o5hxpl8f	19	3	compared	compare	VBD
cord-329200-o5hxpl8f	19	4	these	these	DT
cord-329200-o5hxpl8f	19	5	four	four	CD
cord-329200-o5hxpl8f	19	6	assays	assay	NNS
cord-329200-o5hxpl8f	19	7	and	and	CC
cord-329200-o5hxpl8f	19	8	a	a	DT
cord-329200-o5hxpl8f	19	9	novel	novel	JJ
cord-329200-o5hxpl8f	19	10	384-well	384-well	CD
cord-329200-o5hxpl8f	19	11	ELISA	ELISA	NNP
cord-329200-o5hxpl8f	19	12	detecting	detect	VBG
cord-329200-o5hxpl8f	19	13	total	total	JJ
cord-329200-o5hxpl8f	19	14	IgG	igg	NN
cord-329200-o5hxpl8f	19	15	to	to	IN
cord-329200-o5hxpl8f	19	16	a	a	DT
cord-329200-o5hxpl8f	19	17	trimeric	trimeric	JJ
cord-329200-o5hxpl8f	19	18	spike	spike	NN
cord-329200-o5hxpl8f	19	19	protein	protein	NN
cord-329200-o5hxpl8f	19	20	and	and	CC
cord-329200-o5hxpl8f	19	21	used	use	VBD
cord-329200-o5hxpl8f	19	22	all	all	DT
cord-329200-o5hxpl8f	19	23	five	five	CD
cord-329200-o5hxpl8f	19	24	assays	assay	NNS
cord-329200-o5hxpl8f	19	25	on	on	IN
cord-329200-o5hxpl8f	19	26	976	976	CD
cord-329200-o5hxpl8f	19	27	pre	pre	JJ
cord-329200-o5hxpl8f	19	28	-	-	JJ
cord-329200-o5hxpl8f	19	29	pandemic	pandemic	JJ
cord-329200-o5hxpl8f	19	30	samples	sample	NNS
cord-329200-o5hxpl8f	19	31	presumed	presume	VBN
cord-329200-o5hxpl8f	19	32	to	to	TO
cord-329200-o5hxpl8f	19	33	be	be	VB
cord-329200-o5hxpl8f	19	34	negative	negative	JJ
cord-329200-o5hxpl8f	19	35	,	,	,
cord-329200-o5hxpl8f	19	36	collected	collect	VBN
cord-329200-o5hxpl8f	19	37	between	between	IN
cord-329200-o5hxpl8f	19	38	2014	2014	CD
cord-329200-o5hxpl8f	19	39	and	and	CC
cord-329200-o5hxpl8f	19	40	2016	2016	CD
cord-329200-o5hxpl8f	19	41	,	,	,
cord-329200-o5hxpl8f	19	42	and	and	CC
cord-329200-o5hxpl8f	19	43	536	536	CD
cord-329200-o5hxpl8f	19	44	serum	serum	NN
cord-329200-o5hxpl8f	19	45	samples	sample	NNS
cord-329200-o5hxpl8f	19	46	from	from	IN
cord-329200-o5hxpl8f	19	47	patients	patient	NNS
cord-329200-o5hxpl8f	19	48	with	with	IN
cord-329200-o5hxpl8f	19	49	laboratory	laboratory	NN
cord-329200-o5hxpl8f	19	50	-	-	HYPH
cord-329200-o5hxpl8f	19	51	confirmed	confirm	VBN
cord-329200-o5hxpl8f	19	52	COVID-19	COVID-19	NNP
cord-329200-o5hxpl8f	19	53	from	from	IN
cord-329200-o5hxpl8f	19	54	research	research	NN
cord-329200-o5hxpl8f	19	55	studies	study	NNS
cord-329200-o5hxpl8f	19	56	in	in	IN
cord-329200-o5hxpl8f	19	57	Oxford	Oxford	NNP
cord-329200-o5hxpl8f	19	58	,	,	,
cord-329200-o5hxpl8f	19	59	UK	UK	NNP
cord-329200-o5hxpl8f	19	60	,	,	,
cord-329200-o5hxpl8f	19	61	or	or	CC
cord-329200-o5hxpl8f	19	62	plasma	plasma	NN
cord-329200-o5hxpl8f	19	63	donors	donor	NNS
cord-329200-o5hxpl8f	19	64	.	.	.
cord-329200-o5hxpl8f	20	1	The	the	DT
cord-329200-o5hxpl8f	20	2	authors	author	NNS
cord-329200-o5hxpl8f	20	3	report	report	VBP
cord-329200-o5hxpl8f	20	4	that	that	IN
cord-329200-o5hxpl8f	20	5	all	all	DT
cord-329200-o5hxpl8f	20	6	assays	assay	NNS
cord-329200-o5hxpl8f	20	7	had	have	VBD
cord-329200-o5hxpl8f	20	8	a	a	DT
cord-329200-o5hxpl8f	20	9	high	high	JJ
cord-329200-o5hxpl8f	20	10	sensitivity	sensitivity	NN
cord-329200-o5hxpl8f	20	11	(	(	-LRB-
cord-329200-o5hxpl8f	20	12	92·7	92·7	CD
cord-329200-o5hxpl8f	20	13	-	-	HYPH
cord-329200-o5hxpl8f	20	14	99·1	99·1	CD
cord-329200-o5hxpl8f	20	15	%	%	NN
cord-329200-o5hxpl8f	20	16	)	)	-RRB-
cord-329200-o5hxpl8f	20	17	and	and	CC
cord-329200-o5hxpl8f	20	18	specificity	specificity	NN
cord-329200-o5hxpl8f	20	19	(	(	-LRB-
cord-329200-o5hxpl8f	20	20	98·7	98·7	NNP
cord-329200-o5hxpl8f	20	21	-	-	HYPH
cord-329200-o5hxpl8f	20	22	99·9	99·9	CD
cord-329200-o5hxpl8f	20	23	%	%	NN
cord-329200-o5hxpl8f	20	24	)	)	-RRB-
cord-329200-o5hxpl8f	20	25	.	.	.
cord-329200-o5hxpl8f	21	1	The	the	DT
cord-329200-o5hxpl8f	21	2	most	most	RBS
cord-329200-o5hxpl8f	21	3	sensitive	sensitive	JJ
cord-329200-o5hxpl8f	21	4	test	test	NN
cord-329200-o5hxpl8f	21	5	assessed	assess	VBN
cord-329200-o5hxpl8f	21	6	was	be	VBD
cord-329200-o5hxpl8f	21	7	the	the	DT
cord-329200-o5hxpl8f	21	8	in	in	IN
cord-329200-o5hxpl8f	21	9	-	-	HYPH
cord-329200-o5hxpl8f	21	10	house	house	NN
cord-329200-o5hxpl8f	21	11	ELISA	ELISA	NNP
cord-329200-o5hxpl8f	21	12	.	.	.
cord-329200-o5hxpl8f	22	1	The	the	DT
cord-329200-o5hxpl8f	22	2	Abbott	Abbott	NNP
cord-329200-o5hxpl8f	22	3	,	,	,
cord-329200-o5hxpl8f	22	4	Roche	Roche	NNP
cord-329200-o5hxpl8f	22	5	,	,	,
cord-329200-o5hxpl8f	22	6	and	and	CC
cord-329200-o5hxpl8f	22	7	Siemens	Siemens	NNP
cord-329200-o5hxpl8f	22	8	assays	assay	NNS
cord-329200-o5hxpl8f	22	9	were	be	VBD
cord-329200-o5hxpl8f	22	10	the	the	DT
cord-329200-o5hxpl8f	22	11	most	most	RBS
cord-329200-o5hxpl8f	22	12	specific	specific	JJ
cord-329200-o5hxpl8f	22	13	.	.	.
cord-329200-o5hxpl8f	23	1	The	the	DT
cord-329200-o5hxpl8f	23	2	benefit	benefit	NN
cord-329200-o5hxpl8f	23	3	of	of	IN
cord-329200-o5hxpl8f	23	4	the	the	DT
cord-329200-o5hxpl8f	23	5	huge	huge	JJ
cord-329200-o5hxpl8f	23	6	sample	sample	NN
cord-329200-o5hxpl8f	23	7	bank	bank	NN
cord-329200-o5hxpl8f	23	8	available	available	JJ
cord-329200-o5hxpl8f	23	9	to	to	IN
cord-329200-o5hxpl8f	23	10	these	these	DT
cord-329200-o5hxpl8f	23	11	authors	author	NNS
cord-329200-o5hxpl8f	23	12	was	be	VBD
cord-329200-o5hxpl8f	23	13	the	the	DT
cord-329200-o5hxpl8f	23	14	clearly	clearly	RB
cord-329200-o5hxpl8f	23	15	documented	document	VBN
cord-329200-o5hxpl8f	23	16	time	time	NN
cord-329200-o5hxpl8f	23	17	since	since	IN
cord-329200-o5hxpl8f	23	18	PCR	PCR	NNP
cord-329200-o5hxpl8f	23	19	positivity	positivity	NN
cord-329200-o5hxpl8f	23	20	,	,	,
cord-329200-o5hxpl8f	23	21	which	which	WDT
cord-329200-o5hxpl8f	23	22	allowed	allow	VBD
cord-329200-o5hxpl8f	23	23	them	-PRON-	PRP
cord-329200-o5hxpl8f	23	24	to	to	TO
cord-329200-o5hxpl8f	23	25	optimise	optimise	VB
cord-329200-o5hxpl8f	23	26	the	the	DT
cord-329200-o5hxpl8f	23	27	manufacturers	manufacturer	NNS
cord-329200-o5hxpl8f	23	28	'	'	POS
cord-329200-o5hxpl8f	23	29	cut	cut	VBN
cord-329200-o5hxpl8f	23	30	offs	off	NNS
cord-329200-o5hxpl8f	23	31	and	and	CC
cord-329200-o5hxpl8f	23	32	improve	improve	VB
cord-329200-o5hxpl8f	23	33	sensitivity	sensitivity	NN
cord-329200-o5hxpl8f	23	34	.	.	.
cord-329200-o5hxpl8f	24	1	Only	only	RB
cord-329200-o5hxpl8f	24	2	three	three	CD
cord-329200-o5hxpl8f	24	3	cases	case	NNS
cord-329200-o5hxpl8f	24	4	did	do	VBD
cord-329200-o5hxpl8f	24	5	not	not	RB
cord-329200-o5hxpl8f	24	6	give	give	VB
cord-329200-o5hxpl8f	24	7	rise	rise	NN
cord-329200-o5hxpl8f	24	8	to	to	IN
cord-329200-o5hxpl8f	24	9	any	any	DT
cord-329200-o5hxpl8f	24	10	detectable	detectable	JJ
cord-329200-o5hxpl8f	24	11	antibody	antibody	NN
cord-329200-o5hxpl8f	24	12	responses	response	NNS
cord-329200-o5hxpl8f	24	13	in	in	IN
cord-329200-o5hxpl8f	24	14	all	all	DT
cord-329200-o5hxpl8f	24	15	five	five	CD
cord-329200-o5hxpl8f	24	16	of	of	IN
cord-329200-o5hxpl8f	24	17	the	the	DT
cord-329200-o5hxpl8f	24	18	assays	assay	NNS
cord-329200-o5hxpl8f	24	19	,	,	,
cord-329200-o5hxpl8f	24	20	possibly	possibly	RB
cord-329200-o5hxpl8f	24	21	because	because	IN
cord-329200-o5hxpl8f	24	22	of	of	IN
cord-329200-o5hxpl8f	24	23	a	a	DT
cord-329200-o5hxpl8f	24	24	genuine	genuine	JJ
cord-329200-o5hxpl8f	24	25	lack	lack	NN
cord-329200-o5hxpl8f	24	26	of	of	IN
cord-329200-o5hxpl8f	24	27	response	response	NN
cord-329200-o5hxpl8f	24	28	in	in	IN
cord-329200-o5hxpl8f	24	29	infected	infected	JJ
cord-329200-o5hxpl8f	24	30	individuals	individual	NNS
cord-329200-o5hxpl8f	24	31	,	,	,
cord-329200-o5hxpl8f	24	32	or	or	CC
cord-329200-o5hxpl8f	24	33	a	a	DT
cord-329200-o5hxpl8f	24	34	false	false	JJ
cord-329200-o5hxpl8f	24	35	-	-	HYPH
cord-329200-o5hxpl8f	24	36	positive	positive	JJ
cord-329200-o5hxpl8f	24	37	quantitative	quantitative	JJ
cord-329200-o5hxpl8f	24	38	PCR	pcr	NN
cord-329200-o5hxpl8f	24	39	result	result	NN
cord-329200-o5hxpl8f	24	40	.	.	.
cord-329200-o5hxpl8f	25	1	A	a	DT
cord-329200-o5hxpl8f	25	2	limitation	limitation	NN
cord-329200-o5hxpl8f	25	3	of	of	IN
cord-329200-o5hxpl8f	25	4	this	this	DT
cord-329200-o5hxpl8f	25	5	work	work	NN
cord-329200-o5hxpl8f	25	6	is	be	VBZ
cord-329200-o5hxpl8f	25	7	the	the	DT
cord-329200-o5hxpl8f	25	8	small	small	JJ
cord-329200-o5hxpl8f	25	9	number	number	NN
cord-329200-o5hxpl8f	25	10	of	of	IN
cord-329200-o5hxpl8f	25	11	pauci	pauci	NN
cord-329200-o5hxpl8f	25	12	-	-	HYPH
cord-329200-o5hxpl8f	25	13	symptomatic	symptomatic	JJ
cord-329200-o5hxpl8f	25	14	and	and	CC
cord-329200-o5hxpl8f	25	15	asymptomatic	asymptomatic	JJ
cord-329200-o5hxpl8f	25	16	cases	case	NNS
cord-329200-o5hxpl8f	25	17	analysed	analyse	VBN
cord-329200-o5hxpl8f	25	18	.	.	.
cord-329200-o5hxpl8f	26	1	Antibody	antibody	NN
cord-329200-o5hxpl8f	26	2	responses	response	NNS
cord-329200-o5hxpl8f	26	3	in	in	IN
cord-329200-o5hxpl8f	26	4	these	these	DT
cord-329200-o5hxpl8f	26	5	individuals	individual	NNS
cord-329200-o5hxpl8f	26	6	are	be	VBP
cord-329200-o5hxpl8f	26	7	likely	likely	JJ
cord-329200-o5hxpl8f	26	8	to	to	TO
cord-329200-o5hxpl8f	26	9	be	be	VB
cord-329200-o5hxpl8f	26	10	lower	low	JJR
cord-329200-o5hxpl8f	26	11	,	,	,
cord-329200-o5hxpl8f	26	12	and	and	CC
cord-329200-o5hxpl8f	26	13	therefore	therefore	RB
cord-329200-o5hxpl8f	26	14	the	the	DT
cord-329200-o5hxpl8f	26	15	sensitivity	sensitivity	NN
cord-329200-o5hxpl8f	26	16	of	of	IN
cord-329200-o5hxpl8f	26	17	all	all	DT
cord-329200-o5hxpl8f	26	18	assays	assay	NNS
cord-329200-o5hxpl8f	26	19	might	may	MD
cord-329200-o5hxpl8f	26	20	be	be	VB
cord-329200-o5hxpl8f	26	21	somewhat	somewhat	RB
cord-329200-o5hxpl8f	26	22	less	less	JJR
cord-329200-o5hxpl8f	26	23	than	than	IN
cord-329200-o5hxpl8f	26	24	that	that	DT
cord-329200-o5hxpl8f	26	25	reported	report	VBN
cord-329200-o5hxpl8f	26	26	.	.	.
cord-329200-o5hxpl8f	27	1	Also	also	RB
cord-329200-o5hxpl8f	27	2	,	,	,
cord-329200-o5hxpl8f	27	3	data	datum	NNS
cord-329200-o5hxpl8f	27	4	on	on	IN
cord-329200-o5hxpl8f	27	5	sex	sex	NN
cord-329200-o5hxpl8f	27	6	,	,	,
cord-329200-o5hxpl8f	27	7	age	age	NN
cord-329200-o5hxpl8f	27	8	,	,	,
cord-329200-o5hxpl8f	27	9	and	and	CC
cord-329200-o5hxpl8f	27	10	immunocompromise	immunocompromise	JJ
cord-329200-o5hxpl8f	27	11	status	status	NN
cord-329200-o5hxpl8f	27	12	were	be	VBD
cord-329200-o5hxpl8f	27	13	incomplete	incomplete	JJ
cord-329200-o5hxpl8f	27	14	,	,	,
cord-329200-o5hxpl8f	27	15	meaning	mean	VBG
cord-329200-o5hxpl8f	27	16	that	that	IN
cord-329200-o5hxpl8f	27	17	the	the	DT
cord-329200-o5hxpl8f	27	18	results	result	NNS
cord-329200-o5hxpl8f	27	19	could	could	MD
cord-329200-o5hxpl8f	27	20	be	be	VB
cord-329200-o5hxpl8f	27	21	limited	limit	VBN
cord-329200-o5hxpl8f	27	22	in	in	IN
cord-329200-o5hxpl8f	27	23	their	-PRON-	PRP$
cord-329200-o5hxpl8f	27	24	application	application	NN
cord-329200-o5hxpl8f	27	25	to	to	IN
cord-329200-o5hxpl8f	27	26	specific	specific	JJ
cord-329200-o5hxpl8f	27	27	patient	patient	JJ
cord-329200-o5hxpl8f	27	28	groups	group	NNS
cord-329200-o5hxpl8f	27	29	.	.	.
cord-329200-o5hxpl8f	28	1	This	this	DT
cord-329200-o5hxpl8f	28	2	limitation	limitation	NN
cord-329200-o5hxpl8f	28	3	could	could	MD
cord-329200-o5hxpl8f	28	4	be	be	VB
cord-329200-o5hxpl8f	28	5	especially	especially	RB
cord-329200-o5hxpl8f	28	6	important	important	JJ
cord-329200-o5hxpl8f	28	7	in	in	IN
cord-329200-o5hxpl8f	28	8	children	child	NNS
cord-329200-o5hxpl8f	28	9	,	,	,
cord-329200-o5hxpl8f	28	10	who	who	WP
cord-329200-o5hxpl8f	28	11	are	be	VBP
cord-329200-o5hxpl8f	28	12	more	more	RBR
cord-329200-o5hxpl8f	28	13	likely	likely	JJ
cord-329200-o5hxpl8f	28	14	than	than	IN
cord-329200-o5hxpl8f	28	15	adults	adult	NNS
cord-329200-o5hxpl8f	28	16	are	be	VBP
cord-329200-o5hxpl8f	28	17	to	to	TO
cord-329200-o5hxpl8f	28	18	have	have	VB
cord-329200-o5hxpl8f	28	19	had	have	VBN
cord-329200-o5hxpl8f	28	20	a	a	DT
cord-329200-o5hxpl8f	28	21	recent	recent	JJ
cord-329200-o5hxpl8f	28	22	infection	infection	NN
cord-329200-o5hxpl8f	28	23	with	with	IN
cord-329200-o5hxpl8f	28	24	a	a	DT
cord-329200-o5hxpl8f	28	25	seasonal	seasonal	JJ
cord-329200-o5hxpl8f	28	26	coronavirus	coronavirus	NN
cord-329200-o5hxpl8f	28	27	.	.	.
cord-329200-o5hxpl8f	29	1	The	the	DT
cord-329200-o5hxpl8f	29	2	expectation	expectation	NN
cord-329200-o5hxpl8f	29	3	is	be	VBZ
cord-329200-o5hxpl8f	29	4	that	that	IN
cord-329200-o5hxpl8f	29	5	the	the	DT
cord-329200-o5hxpl8f	29	6	best	good	JJS
cord-329200-o5hxpl8f	29	7	predictor	predictor	NN
cord-329200-o5hxpl8f	29	8	of	of	IN
cord-329200-o5hxpl8f	29	9	antibodymediated	antibodymediated	JJ
cord-329200-o5hxpl8f	29	10	protection	protection	NN
cord-329200-o5hxpl8f	29	11	will	will	MD
cord-329200-o5hxpl8f	29	12	come	come	VB
cord-329200-o5hxpl8f	29	13	from	from	IN
cord-329200-o5hxpl8f	29	14	neutralisation	neutralisation	NN
cord-329200-o5hxpl8f	29	15	assays	assay	NNS
cord-329200-o5hxpl8f	29	16	,	,	,
cord-329200-o5hxpl8f	29	17	in	in	IN
cord-329200-o5hxpl8f	29	18	which	which	WDT
cord-329200-o5hxpl8f	29	19	the	the	DT
cord-329200-o5hxpl8f	29	20	ability	ability	NN
cord-329200-o5hxpl8f	29	21	of	of	IN
cord-329200-o5hxpl8f	29	22	patient	patient	JJ
cord-329200-o5hxpl8f	29	23	serum	serum	NN
cord-329200-o5hxpl8f	29	24	to	to	TO
cord-329200-o5hxpl8f	29	25	prevent	prevent	VB
cord-329200-o5hxpl8f	29	26	live	live	JJ
cord-329200-o5hxpl8f	29	27	virus	virus	NN
cord-329200-o5hxpl8f	29	28	infecting	infect	VBG
cord-329200-o5hxpl8f	29	29	cell	cell	NN
cord-329200-o5hxpl8f	29	30	cultures	culture	NNS
cord-329200-o5hxpl8f	29	31	is	be	VBZ
cord-329200-o5hxpl8f	29	32	measured	measure	VBN
cord-329200-o5hxpl8f	29	33	.	.	.
cord-329200-o5hxpl8f	30	1	These	these	DT
cord-329200-o5hxpl8f	30	2	assays	assay	NNS
cord-329200-o5hxpl8f	30	3	are	be	VBP
cord-329200-o5hxpl8f	30	4	impractical	impractical	JJ
cord-329200-o5hxpl8f	30	5	to	to	TO
cord-329200-o5hxpl8f	30	6	deploy	deploy	VB
cord-329200-o5hxpl8f	30	7	at	at	IN
cord-329200-o5hxpl8f	30	8	scale	scale	NN
cord-329200-o5hxpl8f	30	9	.	.	.
cord-329200-o5hxpl8f	31	1	The	the	DT
cord-329200-o5hxpl8f	31	2	presence	presence	NN
cord-329200-o5hxpl8f	31	3	of	of	IN
cord-329200-o5hxpl8f	31	4	antibodies	antibody	NNS
cord-329200-o5hxpl8f	31	5	against	against	IN
cord-329200-o5hxpl8f	31	6	the	the	DT
cord-329200-o5hxpl8f	31	7	spike	spike	NN
cord-329200-o5hxpl8f	31	8	protein	protein	NN
cord-329200-o5hxpl8f	31	9	of	of	IN
cord-329200-o5hxpl8f	31	10	SARS	SARS	NNP
cord-329200-o5hxpl8f	31	11	-	-	HYPH
cord-329200-o5hxpl8f	31	12	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	31	13	correlates	correlate	VBZ
cord-329200-o5hxpl8f	31	14	well	well	RB
cord-329200-o5hxpl8f	31	15	with	with	IN
cord-329200-o5hxpl8f	31	16	neutralisation	neutralisation	NN
cord-329200-o5hxpl8f	31	17	.	.	.
cord-329200-o5hxpl8f	32	1	2,3	2,3	LS
cord-329200-o5hxpl8f	33	1	The	the	DT
cord-329200-o5hxpl8f	33	2	DiaSorin	DiaSorin	NNPS
cord-329200-o5hxpl8f	33	3	,	,	,
cord-329200-o5hxpl8f	33	4	Siemens	Siemens	NNP
cord-329200-o5hxpl8f	33	5	,	,	,
cord-329200-o5hxpl8f	33	6	and	and	CC
cord-329200-o5hxpl8f	33	7	in	in	IN
cord-329200-o5hxpl8f	33	8	-	-	HYPH
cord-329200-o5hxpl8f	33	9	house	house	NN
cord-329200-o5hxpl8f	33	10	assays	assay	NNS
cord-329200-o5hxpl8f	33	11	measured	measure	VBD
cord-329200-o5hxpl8f	33	12	these	these	DT
cord-329200-o5hxpl8f	33	13	potentially	potentially	RB
cord-329200-o5hxpl8f	33	14	protective	protective	JJ
cord-329200-o5hxpl8f	33	15	antibodies	antibody	NNS
cord-329200-o5hxpl8f	33	16	,	,	,
cord-329200-o5hxpl8f	33	17	with	with	IN
cord-329200-o5hxpl8f	33	18	the	the	DT
cord-329200-o5hxpl8f	33	19	inhouse	inhouse	NN
cord-329200-o5hxpl8f	33	20	ELISA	ELISA	NNP
cord-329200-o5hxpl8f	33	21	using	use	VBG
cord-329200-o5hxpl8f	33	22	trimerised	trimerised	JJ
cord-329200-o5hxpl8f	33	23	spike	spike	NN
cord-329200-o5hxpl8f	33	24	protein	protein	NN
cord-329200-o5hxpl8f	33	25	,	,	,
cord-329200-o5hxpl8f	33	26	which	which	WDT
cord-329200-o5hxpl8f	33	27	shows	show	VBZ
cord-329200-o5hxpl8f	33	28	a	a	DT
cord-329200-o5hxpl8f	33	29	high	high	JJ
cord-329200-o5hxpl8f	33	30	correlation	correlation	NN
cord-329200-o5hxpl8f	33	31	with	with	IN
cord-329200-o5hxpl8f	33	32	neutralisation	neutralisation	NN
cord-329200-o5hxpl8f	33	33	.	.	.
cord-329200-o5hxpl8f	34	1	4	4	LS
cord-329200-o5hxpl8f	34	2	,	,	,
cord-329200-o5hxpl8f	34	3	5	5	CD
cord-329200-o5hxpl8f	34	4	,	,	,
cord-329200-o5hxpl8f	34	5	6	6	CD
cord-329200-o5hxpl8f	35	1	Further	further	JJ
cord-329200-o5hxpl8f	35	2	work	work	NN
cord-329200-o5hxpl8f	35	3	is	be	VBZ
cord-329200-o5hxpl8f	35	4	required	require	VBN
cord-329200-o5hxpl8f	35	5	to	to	TO
cord-329200-o5hxpl8f	35	6	investigate	investigate	VB
cord-329200-o5hxpl8f	35	7	what	what	WP
cord-329200-o5hxpl8f	35	8	titre	titre	NN
cord-329200-o5hxpl8f	35	9	of	of	IN
cord-329200-o5hxpl8f	35	10	neutralising	neutralise	VBG
cord-329200-o5hxpl8f	35	11	antibodies	antibody	NNS
cord-329200-o5hxpl8f	35	12	correlates	correlate	VBZ
cord-329200-o5hxpl8f	35	13	with	with	IN
cord-329200-o5hxpl8f	35	14	protection	protection	NN
cord-329200-o5hxpl8f	35	15	,	,	,
cord-329200-o5hxpl8f	35	16	how	how	WRB
cord-329200-o5hxpl8f	35	17	long	long	JJ
cord-329200-o5hxpl8f	35	18	neutralisation	neutralisation	NN
cord-329200-o5hxpl8f	35	19	activity	activity	NN
cord-329200-o5hxpl8f	35	20	persists	persist	VBZ
cord-329200-o5hxpl8f	35	21	,	,	,
cord-329200-o5hxpl8f	35	22	and	and	CC
cord-329200-o5hxpl8f	35	23	which	which	WDT
cord-329200-o5hxpl8f	35	24	assay	assay	NN
cord-329200-o5hxpl8f	35	25	best	best	RB
cord-329200-o5hxpl8f	35	26	predicts	predict	VBZ
cord-329200-o5hxpl8f	35	27	that	that	DT
cord-329200-o5hxpl8f	35	28	.	.	.
cord-329200-o5hxpl8f	36	1	Identifying	identify	VBG
cord-329200-o5hxpl8f	36	2	an	an	DT
cord-329200-o5hxpl8f	36	3	appropriate	appropriate	JJ
cord-329200-o5hxpl8f	36	4	assay	assay	NN
cord-329200-o5hxpl8f	36	5	will	will	MD
cord-329200-o5hxpl8f	36	6	be	be	VB
cord-329200-o5hxpl8f	36	7	crucial	crucial	JJ
cord-329200-o5hxpl8f	36	8	for	for	IN
cord-329200-o5hxpl8f	36	9	assessing	assess	VBG
cord-329200-o5hxpl8f	36	10	vaccine	vaccine	NN
cord-329200-o5hxpl8f	36	11	responses	response	NNS
cord-329200-o5hxpl8f	36	12	,	,	,
cord-329200-o5hxpl8f	36	13	and	and	CC
cord-329200-o5hxpl8f	36	14	for	for	IN
cord-329200-o5hxpl8f	36	15	assessing	assess	VBG
cord-329200-o5hxpl8f	36	16	potential	potential	JJ
cord-329200-o5hxpl8f	36	17	risk	risk	NN
cord-329200-o5hxpl8f	36	18	of	of	IN
cord-329200-o5hxpl8f	36	19	reinfection	reinfection	NN
cord-329200-o5hxpl8f	36	20	,	,	,
cord-329200-o5hxpl8f	36	21	which	which	WDT
cord-329200-o5hxpl8f	36	22	has	have	VBZ
cord-329200-o5hxpl8f	36	23	been	be	VBN
cord-329200-o5hxpl8f	36	24	shown	show	VBN
cord-329200-o5hxpl8f	36	25	with	with	IN
cord-329200-o5hxpl8f	36	26	seasonal	seasonal	JJ
cord-329200-o5hxpl8f	36	27	coronaviruses	coronaviruse	NNS
cord-329200-o5hxpl8f	36	28	,	,	,
cord-329200-o5hxpl8f	36	29	7	7	CD
cord-329200-o5hxpl8f	36	30	but	but	CC
cord-329200-o5hxpl8f	36	31	not	not	RB
cord-329200-o5hxpl8f	36	32	so	so	RB
cord-329200-o5hxpl8f	36	33	far	far	RB
cord-329200-o5hxpl8f	36	34	for	for	IN
cord-329200-o5hxpl8f	36	35	SARS	SARS	NNP
cord-329200-o5hxpl8f	36	36	-	-	HYPH
cord-329200-o5hxpl8f	36	37	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	36	38	.	.	.
cord-329200-o5hxpl8f	37	1	Consistent	consistent	JJ
cord-329200-o5hxpl8f	37	2	with	with	IN
cord-329200-o5hxpl8f	37	3	this	this	DT
cord-329200-o5hxpl8f	37	4	future	future	JJ
cord-329200-o5hxpl8f	37	5	possibility	possibility	NN
cord-329200-o5hxpl8f	37	6	,	,	,
cord-329200-o5hxpl8f	37	7	the	the	DT
cord-329200-o5hxpl8f	37	8	neutralisation	neutralisation	NN
cord-329200-o5hxpl8f	37	9	potency	potency	NN
cord-329200-o5hxpl8f	37	10	of	of	IN
cord-329200-o5hxpl8f	37	11	serum	serum	NN
cord-329200-o5hxpl8f	37	12	declines	decline	NNS
cord-329200-o5hxpl8f	37	13	in	in	IN
cord-329200-o5hxpl8f	37	14	the	the	DT
cord-329200-o5hxpl8f	37	15	months	month	NNS
cord-329200-o5hxpl8f	37	16	post	post	NN
cord-329200-o5hxpl8f	37	17	infection	infection	NN
cord-329200-o5hxpl8f	37	18	.	.	.
cord-329200-o5hxpl8f	38	1	8	8	CD
cord-329200-o5hxpl8f	38	2	,	,	,
cord-329200-o5hxpl8f	38	3	9	9	CD
cord-329200-o5hxpl8f	39	1	As	as	IN
cord-329200-o5hxpl8f	39	2	our	-PRON-	PRP$
cord-329200-o5hxpl8f	39	3	understanding	understanding	NN
cord-329200-o5hxpl8f	39	4	of	of	IN
cord-329200-o5hxpl8f	39	5	immunity	immunity	NN
cord-329200-o5hxpl8f	39	6	and	and	CC
cord-329200-o5hxpl8f	39	7	the	the	DT
cord-329200-o5hxpl8f	39	8	correlates	correlate	NNS
cord-329200-o5hxpl8f	39	9	of	of	IN
cord-329200-o5hxpl8f	39	10	protection	protection	NN
cord-329200-o5hxpl8f	39	11	(	(	-LRB-
cord-329200-o5hxpl8f	39	12	both	both	DT
cord-329200-o5hxpl8f	39	13	cellular	cellular	JJ
cord-329200-o5hxpl8f	39	14	and	and	CC
cord-329200-o5hxpl8f	39	15	humoral	humoral	JJ
cord-329200-o5hxpl8f	39	16	)	)	-RRB-
cord-329200-o5hxpl8f	39	17	increases	increase	NNS
cord-329200-o5hxpl8f	39	18	and	and	CC
cord-329200-o5hxpl8f	39	19	the	the	DT
cord-329200-o5hxpl8f	39	20	range	range	NN
cord-329200-o5hxpl8f	39	21	of	of	IN
cord-329200-o5hxpl8f	39	22	immunoassays	immunoassays	NNP
cord-329200-o5hxpl8f	39	23	multiplies	multiply	VBZ
cord-329200-o5hxpl8f	39	24	,	,	,
cord-329200-o5hxpl8f	40	1	we	-PRON-	PRP
cord-329200-o5hxpl8f	40	2	will	will	MD
cord-329200-o5hxpl8f	40	3	probably	probably	RB
cord-329200-o5hxpl8f	40	4	Flickr	Flickr	NNP
cord-329200-o5hxpl8f	40	5	-NIAID	-NIAID	.
cord-329200-o5hxpl8f	41	1	use	use	VB
cord-329200-o5hxpl8f	41	2	different	different	JJ
cord-329200-o5hxpl8f	41	3	assays	assay	NNS
cord-329200-o5hxpl8f	41	4	to	to	TO
cord-329200-o5hxpl8f	41	5	answer	answer	VB
cord-329200-o5hxpl8f	41	6	specific	specific	JJ
cord-329200-o5hxpl8f	41	7	questions	question	NNS
cord-329200-o5hxpl8f	41	8	.	.	.
cord-329200-o5hxpl8f	42	1	For	for	IN
cord-329200-o5hxpl8f	42	2	example	example	NN
cord-329200-o5hxpl8f	42	3	,	,	,
cord-329200-o5hxpl8f	42	4	most	most	JJS
cord-329200-o5hxpl8f	42	5	vaccine	vaccine	NN
cord-329200-o5hxpl8f	42	6	candidates	candidate	NNS
cord-329200-o5hxpl8f	42	7	elicit	elicit	VBP
cord-329200-o5hxpl8f	42	8	responses	response	NNS
cord-329200-o5hxpl8f	42	9	to	to	TO
cord-329200-o5hxpl8f	42	10	spike	spike	VB
cord-329200-o5hxpl8f	42	11	rather	rather	RB
cord-329200-o5hxpl8f	42	12	than	than	IN
cord-329200-o5hxpl8f	42	13	nucleocapsid	nucleocapsid	NNP
cord-329200-o5hxpl8f	42	14	protein	protein	NNP
cord-329200-o5hxpl8f	42	15	.	.	.
cord-329200-o5hxpl8f	43	1	Measuring	measure	VBG
cord-329200-o5hxpl8f	43	2	antibodies	antibody	NNS
cord-329200-o5hxpl8f	43	3	to	to	TO
cord-329200-o5hxpl8f	43	4	spike	spike	VB
cord-329200-o5hxpl8f	43	5	will	will	MD
cord-329200-o5hxpl8f	43	6	therefore	therefore	RB
cord-329200-o5hxpl8f	43	7	indicate	indicate	VB
cord-329200-o5hxpl8f	43	8	whether	whether	IN
cord-329200-o5hxpl8f	43	9	there	there	EX
cord-329200-o5hxpl8f	43	10	has	have	VBZ
cord-329200-o5hxpl8f	43	11	been	be	VBN
cord-329200-o5hxpl8f	43	12	a	a	DT
cord-329200-o5hxpl8f	43	13	good	good	JJ
cord-329200-o5hxpl8f	43	14	response	response	NN
cord-329200-o5hxpl8f	43	15	,	,	,
cord-329200-o5hxpl8f	43	16	whereas	whereas	IN
cord-329200-o5hxpl8f	43	17	measuring	measure	VBG
cord-329200-o5hxpl8f	43	18	antibodies	antibody	NNS
cord-329200-o5hxpl8f	43	19	to	to	IN
cord-329200-o5hxpl8f	43	20	nucleocapsid	nucleocapsid	NN
cord-329200-o5hxpl8f	43	21	would	would	MD
cord-329200-o5hxpl8f	43	22	help	help	VB
cord-329200-o5hxpl8f	43	23	identify	identify	VB
cord-329200-o5hxpl8f	43	24	whether	whether	IN
cord-329200-o5hxpl8f	43	25	the	the	DT
cord-329200-o5hxpl8f	43	26	individual	individual	NN
cord-329200-o5hxpl8f	43	27	had	have	VBD
cord-329200-o5hxpl8f	43	28	nonetheless	nonetheless	RB
cord-329200-o5hxpl8f	43	29	become	become	VBN
cord-329200-o5hxpl8f	43	30	infected	infected	JJ
cord-329200-o5hxpl8f	43	31	.	.	.
cord-329200-o5hxpl8f	44	1	Measuring	measure	VBG
cord-329200-o5hxpl8f	44	2	the	the	DT
cord-329200-o5hxpl8f	44	3	different	different	JJ
cord-329200-o5hxpl8f	44	4	antibodies	antibody	NNS
cord-329200-o5hxpl8f	44	5	might	may	MD
cord-329200-o5hxpl8f	44	6	also	also	RB
cord-329200-o5hxpl8f	44	7	have	have	VB
cord-329200-o5hxpl8f	44	8	prognostic	prognostic	JJ
cord-329200-o5hxpl8f	44	9	value	value	NN
cord-329200-o5hxpl8f	44	10	;	;	:
cord-329200-o5hxpl8f	44	11	a	a	DT
cord-329200-o5hxpl8f	44	12	report	report	NN
cord-329200-o5hxpl8f	44	13	showed	show	VBD
cord-329200-o5hxpl8f	44	14	that	that	IN
cord-329200-o5hxpl8f	44	15	a	a	DT
cord-329200-o5hxpl8f	44	16	predominant	predominant	JJ
cord-329200-o5hxpl8f	44	17	humoral	humoral	JJ
cord-329200-o5hxpl8f	44	18	response	response	NN
cord-329200-o5hxpl8f	44	19	to	to	IN
cord-329200-o5hxpl8f	44	20	nucleoprotein	nucleoprotein	NNP
cord-329200-o5hxpl8f	44	21	is	be	VBZ
cord-329200-o5hxpl8f	44	22	associated	associate	VBN
cord-329200-o5hxpl8f	44	23	with	with	IN
cord-329200-o5hxpl8f	44	24	poor	poor	JJ
cord-329200-o5hxpl8f	44	25	outcome	outcome	NN
cord-329200-o5hxpl8f	44	26	in	in	IN
cord-329200-o5hxpl8f	44	27	patients	patient	NNS
cord-329200-o5hxpl8f	44	28	admitted	admit	VBN
cord-329200-o5hxpl8f	44	29	to	to	IN
cord-329200-o5hxpl8f	44	30	hospital	hospital	NN
cord-329200-o5hxpl8f	44	31	,	,	,
cord-329200-o5hxpl8f	44	32	compared	compare	VBN
cord-329200-o5hxpl8f	44	33	with	with	IN
cord-329200-o5hxpl8f	44	34	that	that	DT
cord-329200-o5hxpl8f	44	35	of	of	IN
cord-329200-o5hxpl8f	44	36	spike	spike	NN
cord-329200-o5hxpl8f	44	37	.	.	.
cord-329200-o5hxpl8f	45	1	10	10	CD
cord-329200-o5hxpl8f	46	1	Further	further	JJ
cord-329200-o5hxpl8f	46	2	investigation	investigation	NN
cord-329200-o5hxpl8f	46	3	is	be	VBZ
cord-329200-o5hxpl8f	46	4	required	require	VBN
cord-329200-o5hxpl8f	46	5	and	and	CC
cord-329200-o5hxpl8f	46	6	the	the	DT
cord-329200-o5hxpl8f	46	7	possibility	possibility	NN
cord-329200-o5hxpl8f	46	8	of	of	IN
cord-329200-o5hxpl8f	46	9	a	a	DT
cord-329200-o5hxpl8f	46	10	one	one	CD
cord-329200-o5hxpl8f	46	11	-	-	HYPH
cord-329200-o5hxpl8f	46	12	size	size	NN
cord-329200-o5hxpl8f	46	13	-	-	HYPH
cord-329200-o5hxpl8f	46	14	fits	fit	VBZ
cord-329200-o5hxpl8f	46	15	-	-	HYPH
cord-329200-o5hxpl8f	46	16	all	all	DT
cord-329200-o5hxpl8f	46	17	immunological	immunological	JJ
cord-329200-o5hxpl8f	46	18	assay	assay	NN
cord-329200-o5hxpl8f	46	19	looks	look	VBZ
cord-329200-o5hxpl8f	46	20	less	less	RBR
cord-329200-o5hxpl8f	46	21	and	and	CC
cord-329200-o5hxpl8f	46	22	less	less	RBR
cord-329200-o5hxpl8f	46	23	likely	likely	JJ
cord-329200-o5hxpl8f	46	24	.	.	.
cord-329200-o5hxpl8f	47	1	We	-PRON-	PRP
cord-329200-o5hxpl8f	47	2	declare	declare	VBP
cord-329200-o5hxpl8f	47	3	no	no	DT
cord-329200-o5hxpl8f	47	4	competing	compete	VBG
cord-329200-o5hxpl8f	47	5	interests	interest	NNS
cord-329200-o5hxpl8f	47	6	.	.	.
cord-329200-o5hxpl8f	48	1	The	the	DT
cord-329200-o5hxpl8f	48	2	National	National	NNP
cord-329200-o5hxpl8f	48	3	SARS	SARS	NNP
cord-329200-o5hxpl8f	48	4	-	-	HYPH
cord-329200-o5hxpl8f	48	5	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	48	6	Serology	Serology	NNP
cord-329200-o5hxpl8f	48	7	Assay	Assay	NNP
cord-329200-o5hxpl8f	48	8	Evaluation	Evaluation	NNP
cord-329200-o5hxpl8f	48	9	Group	Group	NNP
cord-329200-o5hxpl8f	48	10	.	.	.
cord-329200-o5hxpl8f	49	1	Performance	performance	NN
cord-329200-o5hxpl8f	49	2	characteristics	characteristic	NNS
cord-329200-o5hxpl8f	49	3	of	of	IN
cord-329200-o5hxpl8f	49	4	five	five	CD
cord-329200-o5hxpl8f	49	5	immunoassays	immunoassay	NNS
cord-329200-o5hxpl8f	49	6	for	for	IN
cord-329200-o5hxpl8f	49	7	SARS	SARS	NNP
cord-329200-o5hxpl8f	49	8	-	-	HYPH
cord-329200-o5hxpl8f	49	9	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	49	10	:	:	:
cord-329200-o5hxpl8f	49	11	a	a	DT
cord-329200-o5hxpl8f	49	12	head	head	NN
cord-329200-o5hxpl8f	49	13	-	-	HYPH
cord-329200-o5hxpl8f	49	14	to	to	IN
cord-329200-o5hxpl8f	49	15	-	-	HYPH
cord-329200-o5hxpl8f	49	16	head	head	NN
cord-329200-o5hxpl8f	49	17	benchmark	benchmark	NN
cord-329200-o5hxpl8f	49	18	comparison	comparison	NN
cord-329200-o5hxpl8f	49	19	.	.	.
cord-329200-o5hxpl8f	50	1	Lancet	Lancet	NNP
cord-329200-o5hxpl8f	50	2	Infect	infect	VB
cord-329200-o5hxpl8f	50	3	Dis	Dis	NNP
cord-329200-o5hxpl8f	50	4	2020	2020	CD
cord-329200-o5hxpl8f	50	5	;	;	:
cord-329200-o5hxpl8f	50	6	published	publish	VBN
cord-329200-o5hxpl8f	50	7	online	online	JJ
cord-329200-o5hxpl8f	50	8	Sept	Sept	NNP
cord-329200-o5hxpl8f	50	9	23	23	CD
cord-329200-o5hxpl8f	50	10	.	.	.
cord-329200-o5hxpl8f	51	1	https://doi.org/10.1016/S1473-3099(20)30634-4	https://doi.org/10.1016/s1473-3099(20)30634-4	RB
cord-329200-o5hxpl8f	51	2	.	.	.
cord-329200-o5hxpl8f	52	1	Severe	severe	JJ
cord-329200-o5hxpl8f	52	2	acute	acute	JJ
cord-329200-o5hxpl8f	52	3	respiratory	respiratory	JJ
cord-329200-o5hxpl8f	52	4	syndrome	syndrome	NN
cord-329200-o5hxpl8f	52	5	coronavirus	coronavirus	NN
cord-329200-o5hxpl8f	53	1	2−specific	2−specific	CD
cord-329200-o5hxpl8f	53	2	antibody	antibody	NN
cord-329200-o5hxpl8f	53	3	responses	response	NNS
cord-329200-o5hxpl8f	53	4	in	in	IN
cord-329200-o5hxpl8f	53	5	coronavirus	coronavirus	NN
cord-329200-o5hxpl8f	53	6	disease	disease	NN
cord-329200-o5hxpl8f	53	7	patients	patient	NNS
cord-329200-o5hxpl8f	53	8	Safety	Safety	NNP
cord-329200-o5hxpl8f	53	9	and	and	CC
cord-329200-o5hxpl8f	53	10	immunogenicity	immunogenicity	NN
cord-329200-o5hxpl8f	53	11	of	of	IN
cord-329200-o5hxpl8f	53	12	the	the	DT
cord-329200-o5hxpl8f	53	13	ChAdOx1	ChAdOx1	NNP
cord-329200-o5hxpl8f	53	14	nCoV-19	ncov-19	CD
cord-329200-o5hxpl8f	53	15	vaccine	vaccine	NN
cord-329200-o5hxpl8f	53	16	against	against	IN
cord-329200-o5hxpl8f	53	17	SARS	SARS	NNP
cord-329200-o5hxpl8f	53	18	-	-	HYPH
cord-329200-o5hxpl8f	53	19	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	53	20	:	:	:
cord-329200-o5hxpl8f	53	21	a	a	DT
cord-329200-o5hxpl8f	53	22	preliminary	preliminary	JJ
cord-329200-o5hxpl8f	53	23	report	report	NN
cord-329200-o5hxpl8f	53	24	of	of	IN
cord-329200-o5hxpl8f	53	25	a	a	DT
cord-329200-o5hxpl8f	53	26	phase	phase	NN
cord-329200-o5hxpl8f	53	27	1/2	1/2	CD
cord-329200-o5hxpl8f	53	28	,	,	,
cord-329200-o5hxpl8f	53	29	single	single	JJ
cord-329200-o5hxpl8f	53	30	-	-	HYPH
cord-329200-o5hxpl8f	53	31	blind	blind	JJ
cord-329200-o5hxpl8f	53	32	,	,	,
cord-329200-o5hxpl8f	53	33	randomised	randomised	JJ
cord-329200-o5hxpl8f	53	34	controlled	control	VBN
cord-329200-o5hxpl8f	53	35	trial	trial	NN
cord-329200-o5hxpl8f	53	36	Convalescent	convalescent	JJ
cord-329200-o5hxpl8f	53	37	plasma	plasma	NN
cord-329200-o5hxpl8f	53	38	therapy	therapy	NN
cord-329200-o5hxpl8f	53	39	for	for	IN
cord-329200-o5hxpl8f	53	40	the	the	DT
cord-329200-o5hxpl8f	53	41	treatment	treatment	NN
cord-329200-o5hxpl8f	53	42	of	of	IN
cord-329200-o5hxpl8f	53	43	patients	patient	NNS
cord-329200-o5hxpl8f	53	44	with	with	IN
cord-329200-o5hxpl8f	53	45	COVID-19	COVID-19	NNP
cord-329200-o5hxpl8f	53	46	:	:	:
cord-329200-o5hxpl8f	53	47	Assessment	assessment	NN
cord-329200-o5hxpl8f	53	48	of	of	IN
cord-329200-o5hxpl8f	53	49	methods	method	NNS
cord-329200-o5hxpl8f	53	50	available	available	JJ
cord-329200-o5hxpl8f	53	51	for	for	IN
cord-329200-o5hxpl8f	53	52	antibody	antibody	NN
cord-329200-o5hxpl8f	53	53	detection	detection	NN
cord-329200-o5hxpl8f	53	54	and	and	CC
cord-329200-o5hxpl8f	53	55	their	-PRON-	PRP$
cord-329200-o5hxpl8f	53	56	correlation	correlation	NN
cord-329200-o5hxpl8f	53	57	with	with	IN
cord-329200-o5hxpl8f	53	58	neutralising	neutralise	VBG
cord-329200-o5hxpl8f	53	59	antibody	antibody	NN
cord-329200-o5hxpl8f	53	60	levels	level	NNS
cord-329200-o5hxpl8f	54	1	Convalescent	convalescent	JJ
cord-329200-o5hxpl8f	54	2	plasma	plasma	NN
cord-329200-o5hxpl8f	54	3	therapy	therapy	NN
cord-329200-o5hxpl8f	54	4	for	for	IN
cord-329200-o5hxpl8f	54	5	the	the	DT
cord-329200-o5hxpl8f	54	6	treatment	treatment	NN
cord-329200-o5hxpl8f	54	7	of	of	IN
cord-329200-o5hxpl8f	54	8	patients	patient	NNS
cord-329200-o5hxpl8f	54	9	with	with	IN
cord-329200-o5hxpl8f	54	10	COVID-19	COVID-19	NNP
cord-329200-o5hxpl8f	54	11	:	:	:
cord-329200-o5hxpl8f	54	12	assessment	assessment	NN
cord-329200-o5hxpl8f	54	13	of	of	IN
cord-329200-o5hxpl8f	54	14	methods	method	NNS
cord-329200-o5hxpl8f	54	15	available	available	JJ
cord-329200-o5hxpl8f	54	16	for	for	IN
cord-329200-o5hxpl8f	54	17	antibody	antibody	NN
cord-329200-o5hxpl8f	54	18	detection	detection	NN
cord-329200-o5hxpl8f	54	19	and	and	CC
cord-329200-o5hxpl8f	54	20	their	-PRON-	PRP$
cord-329200-o5hxpl8f	54	21	correlation	correlation	NN
cord-329200-o5hxpl8f	54	22	with	with	IN
cord-329200-o5hxpl8f	54	23	neutralising	neutralise	VBG
cord-329200-o5hxpl8f	54	24	antibody	antibody	NN
cord-329200-o5hxpl8f	54	25	levels	level	NNS
cord-329200-o5hxpl8f	55	1	SARS	SARS	NNP
cord-329200-o5hxpl8f	55	2	-	-	HYPH
cord-329200-o5hxpl8f	55	3	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	55	4	infection	infection	NN
cord-329200-o5hxpl8f	55	5	induces	induce	VBZ
cord-329200-o5hxpl8f	55	6	robust	robust	JJ
cord-329200-o5hxpl8f	55	7	,	,	,
cord-329200-o5hxpl8f	55	8	neutralizing	neutralize	VBG
cord-329200-o5hxpl8f	55	9	antibody	antibody	NN
cord-329200-o5hxpl8f	55	10	responses	response	NNS
cord-329200-o5hxpl8f	55	11	that	that	WDT
cord-329200-o5hxpl8f	55	12	are	be	VBP
cord-329200-o5hxpl8f	55	13	stable	stable	JJ
cord-329200-o5hxpl8f	55	14	for	for	IN
cord-329200-o5hxpl8f	55	15	at	at	RB
cord-329200-o5hxpl8f	55	16	least	least	RBS
cord-329200-o5hxpl8f	55	17	three	three	CD
cord-329200-o5hxpl8f	55	18	months	month	NNS
cord-329200-o5hxpl8f	55	19	Human	human	JJ
cord-329200-o5hxpl8f	55	20	coronavirus	coronavirus	NN
cord-329200-o5hxpl8f	55	21	NL63	NL63	NNP
cord-329200-o5hxpl8f	55	22	molecular	molecular	JJ
cord-329200-o5hxpl8f	55	23	epidemiology	epidemiology	NN
cord-329200-o5hxpl8f	55	24	and	and	CC
cord-329200-o5hxpl8f	55	25	evolutionary	evolutionary	JJ
cord-329200-o5hxpl8f	55	26	patterns	pattern	NNS
cord-329200-o5hxpl8f	55	27	in	in	IN
cord-329200-o5hxpl8f	55	28	rural	rural	JJ
cord-329200-o5hxpl8f	55	29	coastal	coastal	JJ
cord-329200-o5hxpl8f	55	30	Kenya	Kenya	NNP
cord-329200-o5hxpl8f	55	31	Longitudinal	Longitudinal	NNP
cord-329200-o5hxpl8f	55	32	analysis	analysis	NN
cord-329200-o5hxpl8f	55	33	of	of	IN
cord-329200-o5hxpl8f	55	34	clinical	clinical	JJ
cord-329200-o5hxpl8f	55	35	serology	serology	NN
cord-329200-o5hxpl8f	55	36	assay	assay	NN
cord-329200-o5hxpl8f	55	37	performance	performance	NN
cord-329200-o5hxpl8f	55	38	and	and	CC
cord-329200-o5hxpl8f	55	39	neutralising	neutralise	VBG
cord-329200-o5hxpl8f	55	40	antibody	antibody	NN
cord-329200-o5hxpl8f	55	41	levels	level	NNS
cord-329200-o5hxpl8f	55	42	in	in	IN
cord-329200-o5hxpl8f	55	43	COVID19	COVID19	NNP
cord-329200-o5hxpl8f	55	44	convalescents	convalescent	VBZ
cord-329200-o5hxpl8f	55	45	Clinical	clinical	JJ
cord-329200-o5hxpl8f	55	46	and	and	CC
cord-329200-o5hxpl8f	55	47	immunological	immunological	JJ
cord-329200-o5hxpl8f	55	48	assessment	assessment	NN
cord-329200-o5hxpl8f	55	49	of	of	IN
cord-329200-o5hxpl8f	56	1	asymptomatic	asymptomatic	JJ
cord-329200-o5hxpl8f	56	2	SARS	SARS	NNP
cord-329200-o5hxpl8f	56	3	-	-	HYPH
cord-329200-o5hxpl8f	56	4	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	56	5	infections	infection	NNS
cord-329200-o5hxpl8f	56	6	Distinct	distinct	JJ
cord-329200-o5hxpl8f	56	7	early	early	JJ
cord-329200-o5hxpl8f	56	8	serological	serological	JJ
cord-329200-o5hxpl8f	56	9	signatures	signature	NNS
cord-329200-o5hxpl8f	56	10	track	track	VBP
cord-329200-o5hxpl8f	56	11	with	with	IN
cord-329200-o5hxpl8f	56	12	SARS	SARS	NNP
cord-329200-o5hxpl8f	56	13	-	-	HYPH
cord-329200-o5hxpl8f	56	14	CoV-2	CoV-2	NNP
cord-329200-o5hxpl8f	56	15	survival	survival	NN